Member Info for Gheko

One of our big shareholders on the buying again?

£10k purchase gone through at 1.14p.

Onwards and upwards

On any other day this would be up 30%+

General market tumbling is the only drag. Once things settle down there will be some ver6 cheap shares out there, this one included.

Great news. Another £2.5 million inbound and patent secured for US market. All coming together for new management team with strategic review announcement due in a couple of weeks or so.

Annoying the RNS not showing on this site…..again! Link below for anyone not seen it

https://www.londonstockexchange.com/news-article/FUM/formal-grant-of-us-patent/17507856

I like the comment right at the end of the presentation that Fab are open to collaborations. Wonder what discussions there were in the coffee breaks!

Not showing on this site again.

Link for anyone not seen it this morning

https://www.londonstockexchange.com/news-article/GDR/holding-s-in-company/17499235

In terms of risk profile for this company at the moment, anyone think that the risk of their offices being at the airport in Israel in middle of Middle Eastern war zone at the moment is priced in?!

Been a few big trades over the last couple of sessions with £10k blocks being bought.

Good update video which shows that the survey is all going to p,an and more news coming in very short term. Add that to the Houston conference for deals to be done and you are looking at a potential multi baggers in the making before any drilling has actually begun for 7 billion barrel prize.

Still a micro cap valuation for what they are sitting on. Good luck all. The ride is coming!

“Where deals happen”!!

Https://polaris.brighterir.com/public/helium_one/news/rns/story/x5e3l8x

Well done Cheapie. Great news.

Pleased they moving so fast on to the final two stages. All the while no doubt discussions continue in terms of a farm out. Which of the big majors is going to blink first and want in.

Could end up in a bidding war! Tiny market cap for de risking 7 billion barrel target.

As I said before this is a lifestyle company. No special dividends ever been paid, one portfolio company gone belly up and now dilution again! Ok to trade for the odd 10% but otherwise you can see the pattern over many years.

Great RNS. Can see the new management getting a grip on this. Rise in revenues shows that the faith the management have in their products is showing through. This is only the start and expecting great things from the new team.

Tiny market cap means upside is substantial as a take out bid is a high probability in my view. Either way very cheap as a great recovery stock.

Tiny market cap here for what we have. Only 125 million shares in issue too so the upside is huge when the contracts currently being negotiated land.

As we know, when this moves it moves quickly.

Great looking chart. Breakout above 1.3 and next target circa 2.1.

As news sinks in and folk realise the microcap this company has and strategic review announcement due anytime then this re rates way beyond the next chart target of 2.1.

Always nice getting in early before the crowds arrive.

We could be soon owning the only sexual health OTC treatment for women. Think of worldwide sales of that!

No wonder the board were happy to align their incentives to 4x the placing price at least. As folk start to appreciate just how huge this is the re rate will be truly on.

Good luck with that Weather! Never have despite Bellascura being ripe for one( never happened and now bust). Not happened with Lucyd (now they own next to nothing). SALT they could have done for ages but haven’t.

Guident hype will temp inflate the price here but will quickly evaporate imho unless they finally issue a special dividend which they have never done.

As I have said before they could also have sold a few shares instead of more placements but they issue more shares instead. Think the next round will be due soon.

Was always loads of potential here but awful treatment of shareholders.

RNS’s not showing across the LSE platform.

Opportunity for those who have seen the update to get in at these bargain prices. Building nicely for the breakout to 2p plus.

Remember the board are incentivised to build the company with a share price of 4p + before they get warrants etc.

Continuing to invest in this.

Why if the results at LUCY ar3 so good do their board need to say they INTEND to buy share?! You just buy them and tell the market.

TEK only hold a tiny amount of LUCY stock anyway so not really any news for TEK. BELL already gone bust, Genip pumped and dumped and still no timeline for Guident. Even if Guident does float I don’t see TEK giving any special dividends to shareholders here as he never has done. Begging bowl must be due again soon.

If Guident ends up being listed and valuation looks decent then a direct investment in that might be a good investment. But here, same old story, dad RNS’s what his son at LUCY is doing. Mmmm.

Great find Gtc.

We have the best in class platform which is therefore hugely valuable not only to NCI but to big pharma sand smaller pharma alike.

We know the size of deals in this industry….HUGE! So not only do I think the NCI will need/want a big deal with FAB but other pharmas will be circling.

News anytime and no wonder the price is starting to creep up. The upside is mouthwatering. Good luck all.

If 5bats true Spider the board should reject it as their incentive is to get the share price circa 4x the current price so their nice incentive options kick in!

Anyway 2026 going to be v interesting with new management and strategic review results to be announced soon.